Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers
This is my archive
Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States
Health Economic Considerations in the Deployment of an Alzheimer’s Prevention Therapy
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population
A Literature Review on the Burden of Alzheimer’s Disease on Care Partners
Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care
A framework for addressing Alzheimer’s disease: Without a frame, the work has no aim
Improving community health-care systems’ early detection of cognitive decline and dementia
